Dicerna Pharmaceuticals Inc. (DRNA) Climbed 5.73% or 0.58 To Price $10.7 On Wednesday


Dicerna Pharmaceuticals Inc. (DRNA) climbed 5.73% or 0.58 to $10.7. It is nearly 238095 shares traded, which is 51.66% compare to the average total volume 460906. The market cap of DRNA is $553.91 million. The year to date change is 8.12%. The 52 week price range is from $2.69 to $15.0. Price of DRNA have changed 5.64% during last week. It have changed -27.04% over last month, 20.05% over last 3 months, 73.58% over last 6 months and 191.64% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 11.15. It is 4.21% above current price. The 200-day Moving Averages for DRNA is 7.15. It is -33.18% below current price. The 52-week High is 15.0. It is 40.19% from the current price. The 52-week Low is 2.69. It is -74.86% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DRNA is 2.09 on 2018-03-15. Short % to float is 1.90%. There are some statistics of DRNA. It is has market cap $553.91 million. The share outstanding is 51.77 million. The average volume is 460906. The revenue is 859000. The percent of top 15 Institution holding is 79.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -112.52%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -93.11%.


Tags:

Share this post